FDA Approved: LYMPHIR — Original Application (Citius Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved LYMPHIR (denileukin diftitox-CXDL) through an original application for the treatment of CD25-expressing cutaneous T-cell lymphoma in adults. The ap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• LYMPHIR (DENILEUKIN DIFTITOX-CXDL)

Snippet

ORIG AP for LYMPHIR (DENILEUKIN DIFTITOX-CXDL)